WMGIZ Profile
WMGIZ is the ticker symbol for the contingent value rights (CVRs) issued in connection with the acquisition of Wright Medical Group by Stryker Corporation. The CVRs represent a contractual right to receive future payments based on certain milestones related to the commercialization of Wright Medical Group's Cartiva SCI product.
Under the terms of the agreement, each CVR entitles the holder to receive up to $1.50 in cash upon achievement of certain milestones related to the Cartiva SCI product. The milestones include achieving specific revenue targets and obtaining regulatory approvals in certain jurisdictions.
The CVRs are traded on the NASDAQ Global Select Market under the symbol WMGIZ. The CVRs are set to expire on December 31, 2025, or upon the achievement of the final milestone, whichever occurs earlier. It is important to note that the value of the CVRs may fluctuate based on a variety of factors, including the achievement of the milestones and overall market conditions.
|
